If you are a packaging manufacturer dealing with high carbon footprints and weak materials — this project developed a crystalline cellulose additive that replaces fossil chemicals and improves board strength. It leverages a process that is 95% efficient compared to 40-50% for other commercial methods.
Industrial-Scale Production of Low-Cost Bio-Based Crystalline Cellulose for Diverse Materials
Imagine turning wood scraps into a high-performance 'bio-glue' or strengthening agent. This process uses a special treatment to extract crystalline cellulose from hardwood waste much more efficiently than current methods. It's like upgrading a basic recycling process into a high-tech factory that makes a versatile ingredient for everything from batteries to cardboard.
What needed solving
Industries rely on expensive, fossil-based chemicals for strength and thickness in materials. Current bio-based alternatives are often too expensive or energy-intensive to produce at scale.
What was built
An industrial-scale production line for micro-crystalline cellulose and a testing framework linked to end-user performance requirements.
Who needs this
Who can put this to work
If you are an energy storage company dealing with unstable battery binders — this project developed a colloidally stable micro-crystalline cellulose. This material serves as a high-performance binder for batteries, reducing reliance on fossil-based chemicals.
If you are a chemical manufacturer dealing with expensive, energy-intensive production of thickeners — this project developed a production method with energy usage ~3 times lower than alternatives. This allows for a competitive price even against other abundant chemicals.
Quick answers
How does the cost of this material compare to existing options?
The project aims to achieve a competitive price even against other abundant chemicals, making it significantly more affordable than cellulose materials with comparable properties.
What is the planned industrial scale of production?
The project will build a first-of-a-kind flagship biorefinery producing 4 kt/y by 2029, with a subsequent replication phase to reach 20 kt/y by 2030.
Is the technology protected by intellectual property?
Yes, the project leverages Fibenol's patented Sunburst™ pre-treatment and existing IP to ensure freedom to operate and rapid commercial exploitation.
What is the timeline for the first industrial plant?
The first flagship MCC biorefinery is scheduled to be producing 4 kt/y by 2029.
How does the energy efficiency compare to other processes?
Based on available project data, the energy usage is approximately 3 times lower than alternative commercial processes.
Who built it
The consortium is heavily industry-weighted with 5 industrial partners (56% of the group), including global players like DS Smith, Coatex, and Skeleton Technologies. This structure ensures that the 2 universities and 2 research centers are developing the material specifically for commercial viability and immediate integration into existing product lines.
Contact FIBENOL IMAVERE OU in Estonia regarding the Sunburst™ process
Talk to the team behind this work.
Contact us to find licensing opportunities for the Sunburst™ pre-treatment technology.